C. Almeida

发表

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant

I. James, F. Christiansen, S. Mallal, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study.

S. Mallal, A. Rauch, Annalise M. Martin, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of α-Tocopherol and Mixed Tocopherol Supplementation on Markers of Oxidative Stress and Inflammation in Type 2 Diabetes

Natalie C. Ward, J. Hodgson, I. Puddey, 2007 .

New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals.

I. James, S. Mallal, J. Montaner, 2020, Human immunology.

Genetic characterization of patients with MHC class I mediated abacavir hypersensitivity reaction

S. Mallal, J. Montaner, M. Cavassini, 2007 .

External Quality Assessment of HLA-B*5701 Reporting: An International Multicentre Survey

S. Mallal, M. Gill, C. Mamotte, 2007, Antiviral therapy.

Pharmacogenetics and clinical characteristics of patch test confirmed patients with Abacavir hypersensitivity

S. Mallal, J. Montaner, S. Knowles, 2006 .

Immune responses to abacavir in antigen-presenting cells from hypersensitive patients

I. James, S. Mallal, J. McCluskey, 2007, AIDS.

Abacavir hypersensitivity in HLA-B57-positive individuals with HIV infection is dependent upon the conventional MHC-I Ag presentation pathway

S. Mallal, J. McCluskey, J. Rossjohn, 2007 .

HIV escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopes

D. Heckerman, M. John, S. Mallal, 2013, AIDS.

Translation of HLA–HIV Associations to the Cellular Level: HIV Adapts To Inflate CD8 T Cell Responses against Nef and HLA-Adapted Variant Epitopes

D. Heckerman, R. Haubrich, C. Kadie, 2011, The Journal of Immunology.

Persistent HIV‐1 replication does not explain low levels of T‐cell interferon‐γ mRNA and elevated serum NO2–/NO3– in patients with stable CD4 T‐cell responses to HAART

P. Price, M. French, C. Almeida, 2004, Clinical and experimental immunology.

Use of the ELISpot assay to detect abacavir- and nevirapine-induced IFN-g responses in PBMC from HIV-infected patients with abacavir or nevirapine hypersensitivity reactions

S. Mallal, D. Marriott, A. Kelleher, 2007 .

Abacavir stimulates Hsp70 redistribution in Antigen-presenting cells of patients with hypersensitivity: Association with Type-I alcohol dehydrogenase activity

I. James, S. Mallal, J. McCluskey, 2005 .

Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses.

M. John, S. Mallal, K. Pfafferott, 2009, Journal of immunological methods.

Brief Communication: Immune Activation in Patients Infected with HIV Type 1 and Maintaining Suppression of Viral Replication by Highly Active Antiretroviral Therapy

P. Price, M. French, C. Almeida, 2002 .

Adaptation to HLA-associated immune pressure over the course of HIV infection and in circulating HIV-1 strains

M. John, S. Mallal, S. Gaudieri, 2022, PLoS pathogens.

Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.

David Nolan, Nicholas A Williamson, James McCluskey, 2008, Immunity.

High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection

D. Heckerman, M. John, I. James, 2011, Immunology and cell biology.

Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses.

D. Heckerman, C. Kadie, M. John, 2010, Vaccine.

Predicting and diagnosing abacavir and nevirapine drug hypersensitivity: from bedside to bench and back again.

S. Mallal, A. Rauch, Annalise M. Martin, 2006, Pharmacogenomics.

A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome

S. Mallal, E. Phillips, Annalise M. Martin, 2006, Pharmacogenetics and genomics.

Cytokine Profiling in Abacavir Hypersensitivity Patients

I. James, S. Mallal, E. Phillips, 2008, Antiviral therapy.

Drug‐induced alloreactivity: A new paradigm for allorecognition

M. John, C. Witt, L. D'Orsogna, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Virus-specific T-cell clonotypes might contribute to drug hypersensitivity reactions through heterologous immunity.

M. John, C. Witt, L. D'Orsogna, 2019, The Journal of allergy and clinical immunology.

Stimulation of HIV-specific T cell clonotypes using allogeneic HLA.

M. John, C. Witt, L. D'Orsogna, 2017, Cellular immunology.

Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy.

P. Price, M. French, C. Almeida, 2002, AIDS research and human retroviruses.

Carriage of HLA-B*5701 and a haplotypic Hsp70-Hom variant is associated with a Class I MHC-restricted hypersensitivity response to abacavir

I. James, F. Christiansen, S. Mallal, 2004 .

Effects of alpha-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes.

J. Hodgson, I. Puddey, Jason H. Y. Wu, 2007, Clinical chemistry.

Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV Cohort

S. Mallal, Annalise M. Martin, C. Almeida, 2005 .

Host MHC influences susceptibility to hypersensitivity reactions to two drugs commonly used in HIV therapy

C. Moore, I. James, F. Christiansen, 2005 .